Gayatri Dwarkar
Head of Investor Relations
Replay available
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) Q1 2026 earnings conference call, held 2026-05-07. Replay captured from the company's public earnings webcast.

Head of Investor Relations
Founder and Chief Executive Officer
Chief Commercial Officer
Chief Endocrinologist
Chief Financial Officer
Analyst, LeRinc Partners
Analyst, Evercore
Analyst, Morgan Stanley
Watch the replay and follow the connected company analysis, news, and investor updates for Crinetics Pharmaceuticals, Inc..
WEBVTT 00:00:00.031 -- 00:00:04.577 Hello, everyone. Thank you for joining us and welcome to the Krenetics Pharmaceuticals 00:00:04.577 -- 00:00:09.645 first quarter 2026 financial results. After today's prepared remarks, we will 00:00:09.645 -- 00:00:14.291 host a question and answer session. If you would like to ask a question, please press 00:00:14.291 -- 00:00:18.637 star one to raise your hand. To withdraw your question, press star one again. 00:00:18.637 -- 00:00:24.285 I will now hand the conference over to Gayatri Dwarkar, Head of Investor Relations. 00:00:24.285 -- 00:00:27.266 Gayatri, please go ahead. 00:00:27.588 -- 00:00:30.171 Thank you, operator. Good afternoon, everyone. 00:00:30.171 -- 00:00:33.535 And thank you for joining us. Thank you, operator. 00:00:33.535 -- 00:00:38.600 Good afternoon, everyone. And thank you for joining us to discuss the first quarter 2026 00:00:38.600 -- 00:00:40.222 results. 00:00:40.222 -- 00:00:44.807 Today on the call, we have Dr. Scott Struthers, founder and chief executive officer, 00:00:44.807 -- 00:00:49.252 Isabel Califonos, chief commercial officer, Dr. 00:00:49.252 -- 00:00:54.638 Alan Krasner, chief endocrinologist, and Toby Schilke, chief financial officer. 00:00:54.638 -- 00:00:59.006 Please note there's a slide deck for today's presentation, which is in the events and 00:00:59.006 -- 00:01:03.654 presentation section of the investors page on the Krenetics website. 00:01:03.654 -- 00:01:08.603 In addition, a press release was issued earlier today and is also available on the corporate 00:01:08.603 -- 00:01:13.839 website. Slide two. As a reminder, we'll be making forward-looking 00:01:13.839 -- 00:01:18.684 statements, and I invite you to learn more about the risks and uncertainties associated 00:01:18.684 -- 0...